Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18777990 | 1.00 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777888 | 1.00 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777848 | 1.00 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777897 | 0.99 | KDM4E (0.38) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL12268711 | 0.99 | KDM4E (0.38) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777843 | 0.99 | KDM4E (0.38) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777986 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777933 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777844 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2NPC1 | |
| SCHEMBL18777935 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11522138-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2022-12-06 | — | — | US | disclosed |
| US-20170117487-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
| US-20170117487-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170117487-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | RECQL, HSF1, DDX41 | KDM4E 2319/4885ATM 1948/4885L3MBTL1 1123/4885 |
| US-11522138-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device | RECQL, HSF1, DDX41 | KDM4E 2319/4885ATM 1948/4885L3MBTL1 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.